Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Citi
Cipla
Dow
Fuji
US Army
Deloitte
Healthtrust
McKesson
Chinese Patent Office

Generated: August 19, 2017

DrugPatentWatch Database Preview

ANEXSIA 5/325 Drug Profile

« Back to Dashboard

What is the patent landscape for Anexsia 5/325, and what generic Anexsia 5/325 alternatives are available?

Anexsia 5/325 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in ANEXSIA 5/325 is acetaminophen; hydrocodone bitartrate. There are sixty-six drug master file entries for this compound. Eighty-three suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Summary for Tradename: ANEXSIA 5/325

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list8
Bulk Api Vendors: see list98
Clinical Trials: see list162
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ANEXSIA 5/325 at DailyMed

Pharmacology for Tradename: ANEXSIA 5/325

Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt
ANEXSIA 5/325
acetaminophen; hydrocodone bitartrate
TABLET;ORAL040409-001Oct 20, 2000AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Fuji
US Army
Deloitte
Daiichi Sankyo
Cerilliant
Chubb
US Department of Justice
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot